S-09 Endodontic Implications of Medication-related Osteonecrosis of the Jaw: Practical Considerations & Clinical Pearls
Already registered or subscribed but not seeing access?
Log in now.
CE Hours: 1.0
Description: Medication-related osteonecrosis of the Jaw (MRONJ) is a serious side effect of bone-modifying agents, such as bisphosphonates, denosumab, and antiangiogenic drugs. Persistent disease following root canal treatment and surgical endodontic therapy may increase the risk for MRONJ. In this session, we will discuss practical approaches to recognize risk factors, risk mitigation strategies, and MRONJ management for patients requiring surgical and non-surgical endodontic therapy.
Learning Objectives:
- Identify risk factors for MRONJ.
- Identify methods to reduce the risk of MRONJ.
- Describe the assessment and management of MRONJ.
This content will not be available until 07/01/2026 at 12:00 AM (CDT)